Lysyl Oxidase Homolog 2/LOXL2 Antibody [Biotin]
Novus Biologicals, part of Bio-Techne | Catalog # AF2639B
Conjugate
Catalog #
Key Product Details
Species Reactivity
Human
Applications
Immunohistochemistry, Western Blot, Immunoprecipitation
Label
Biotin
Antibody Source
Polyclonal Goat IgG
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Product Specifications
Immunogen
Mouse myeloma cell line NS0-derived recombinant human Lysyl Oxidase Homolog 2/LOXL2
Gln26-Gln774
Accession # AAH00594
Gln26-Gln774
Accession # AAH00594
Specificity
Detects human Lysyl Oxidase Homolog 2/LOXL2 in direct ELISAs and Western blots.
Clonality
Polyclonal
Host
Goat
Isotype
IgG
Applications for Lysyl Oxidase Homolog 2/LOXL2 Antibody [Biotin]
Application
Recommended Usage
Immunohistochemistry
Optimal dilutions of this antibody should be experimentally determined.
Immunoprecipitation
Optimal dilutions of this antibody should be experimentally determined.
Western Blot
Optimal dilutions of this antibody should be experimentally determined.
Application Notes
Optimal dilution of this antibody should be experimentally determined.
Formulation, Preparation, and Storage
Purification
Antigen Affinity-purified
Formulation
PBS
Preservative
0.05% Sodium Azide
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Shipping
The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
Store at 4C in the dark.
Background: Lysyl Oxidase Homolog 2/LOXL2
Alternate Names
LOL2, LOXL2
Gene Symbol
LOXL2
Additional Lysyl Oxidase Homolog 2/LOXL2 Products
Product Documents for Lysyl Oxidase Homolog 2/LOXL2 Antibody [Biotin]
Product Specific Notices for Lysyl Oxidase Homolog 2/LOXL2 Antibody [Biotin]
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
Loading...
Loading...
Loading...
Loading...